A Regulatory Science Perspective on Warfarin Therapy: A Pharmacogenetic Opportunity

A Rapid-ACCE review of CYP2C9 and VKORC1 alleles testing to inform warfarin dosing in adults at elevated risk for thrombotic events to avoid serious bleeding

(2009) Monica R McClain et al.   GENETICS IN MEDICINE

Pharmacology and Management of the Vitamin K Antagonists

(2008) Jack Ansell et al.   CHEST

Warfarin and Pharmacogenomic Testing: The Case for Restraint

(2008) DA Garcia   CLINICAL PHARMACOLOGY & THERAPEUTICS

Prospective Study of Warfarin Dosage Requirements Based on CYP2C9 and VKORC1 Genotypes

(2008) M-S Wen et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin

(2008) BF Gage et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The Critical Path of Warfarin Dosing: Finding an Optimal Dosing Strategy Using Pharmacogenetics

(2008) LJ Lesko   CLINICAL PHARMACOLOGY & THERAPEUTICS

Dosing Algorithms to Predict Warfarin Maintenance Dose in Caucasians and African Americans

(2008) H Schelleman et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Is This the Drug or Dose for You?: Impact and Consideration of Ethnic Factors in Global Drug Development, Regulatory Review, and Clinical Practice

(2008) S-M Huang et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

Pharmacogenomics of 4-Hydroxycoumarin Anticoagulants

(2008) Nicholas Au et al.   DRUG METABOLISM REVIEWS

Healthcare impact of personalized medicine using genetic testing: an exploratory analysis for warfarin

(2008) Andrew McWilliam et al.   Personalized Medicine